• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸增强磁共振成像中,在廓清基础上增加过渡期和肝胆期对厘米以下肝细胞癌的诊断效能

Diagnostic performances of adding transition and hepatobiliary phase to washout in gadoxetic acid-enhanced MRI for subcentimeter hepatocellular carcinoma.

作者信息

Yang Li, Rao Shengxiang, Jin Kaipu, Wu Lifang, Zeng Mengsu, Ding Ying

机构信息

Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China.

Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

出版信息

BMC Gastroenterol. 2025 Jul 1;25(1):483. doi: 10.1186/s12876-025-04071-y.

DOI:10.1186/s12876-025-04071-y
PMID:40596938
Abstract

OBJECTIVE

To compare the diagnostic performances of washout (WO) criteria confined to portal venous phase (PVP), extended to transition phase (TP) or hepatobiliary phase (HBP) for subcentimeter hepatocellular carcinoma (HCC) using gadoxetic acid-enhanced MRI.

MATERIALS AND METHODS

Two hundred patients (mean age, 53.4 ± 10.4 years) who were scanned with 1.5-T gadoxetic acid-enhanced MRI were included. Arterial phase hyperenhancement and signal intensity on PVP, TP and HBP images were evaluated. Three WO criteria were established: WO confined to the PVP, WO extended to the TP and WO extended to the HBP.

ASSESSMENT

Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy with 95% confidence interval were calculated for WO confined to the PVP and WO extended to the TP or HBP, and generalized estimating equation was used to compare sensitivity, specificity, PPV, NPV and accuracy.

RESULTS

A total of 200 surgically confirmed subcentimeter hepatic nodules (171 HCCs and 29 non-HCCs) were included. For solitary subcentimeter HCCs, WO extended to the TP showed significantly higher sensitivity and accuracy than WO confined to the PVP (70.80% vs. 49.64%, P < 0.05; 71.52% vs. 55.70%, P < 0.001) and AFP (70.80% vs. 51.09%, P < 0.05; 71.52% vs. 55.70%, P < 0.05), but no significant difference in specificity (76.19% vs. 95.24%, P > 0.05; 76.19% vs. 85.71%, P > 0.05). Extending WO to the HBP achieved significantly higher sensitivity (78.10% vs. 49.64%, P < 0.001; 78.10% vs. 70.80%, P < 0.05) and accuracy (75.32% vs. 55.70%, P < 0.001; 75.32% vs. 71.52%, P < 0.05) compared to WO confined to the PVP and WO extended to the TP, but lower specificity (57.14%% vs. 95.24%, P < 0.05) compared to WO confined to the PVP. The combination of AFP with WO confined to the PVP, WO extended to the TP, or WO extended to the HBP yielded significantly higher sensitivities and accuracies compared to each MRI washout criterion alone (all P < 0.001).

CONCLUSION

WO extending to TP rather than HBP may be a preferred alternative for diagnosing subcentimeter HCC, and the supplement of AFP may improve sensitivity and accuracy.

摘要

目的

使用钆塞酸二钠增强磁共振成像(MRI)比较局限于门静脉期(PVP)、扩展至门脉-肝实质移行期(TP)或肝胆期(HBP)的廓清(WO)标准对亚厘米级肝细胞癌(HCC)的诊断效能。

材料与方法

纳入200例行1.5-T钆塞酸二钠增强MRI扫描的患者(平均年龄53.4±10.4岁)。评估动脉期高增强以及PVP、TP和HBP图像上的信号强度。建立了三个WO标准:局限于PVP的WO、扩展至TP的WO和扩展至HBP的WO。

评估

计算局限于PVP的WO以及扩展至TP或HBP的WO的敏感度、特异度、阳性预测值(PPV)、阴性预测值(NPV)和95%置信区间的准确度,并使用广义估计方程比较敏感度、特异度、PPV、NPV和准确度。

结果

共纳入200个经手术证实的亚厘米级肝结节(171个HCC和29个非HCC)。对于孤立性亚厘米级HCC,扩展至TP的WO显示出比局限于PVP的WO显著更高的敏感度和准确度(70.80%对49.64%,P<0.05;71.52%对55.70%,P<0.001)以及甲胎蛋白(AFP)(70.80%对51.09%,P<0.05;71.52%对55.70%,P<0.05),但特异度无显著差异(76.19%对95.24%,P>0.05;76.19%对85.71%,P>0.05)。与局限于PVP的WO和扩展至TP的WO相比,扩展至HBP的WO实现了显著更高的敏感度(78.10%对49.64%,P<0.001;78.10%对70.80%,P<0.05)和准确度(75.32%对55.70%,P<0.001;75.32%对71.52%,P<0.05),但与局限于PVP的WO相比特异度较低(57.14%对95.24%,P<0.05)。与单独的每个MRI廓清标准相比,AFP与局限于PVP的WO、扩展至TP的WO或扩展至HBP的WO联合使用产生了显著更高的敏感度和准确度(所有P<0.001)。

结论

扩展至TP而非HBP的WO可能是诊断亚厘米级HCC的首选替代方法,AFP的补充可能提高敏感度和准确度。

相似文献

1
Diagnostic performances of adding transition and hepatobiliary phase to washout in gadoxetic acid-enhanced MRI for subcentimeter hepatocellular carcinoma.钆塞酸增强磁共振成像中,在廓清基础上增加过渡期和肝胆期对厘米以下肝细胞癌的诊断效能
BMC Gastroenterol. 2025 Jul 1;25(1):483. doi: 10.1186/s12876-025-04071-y.
2
An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI.基于钆塞酸增强 MRI 的亚厘米肝癌改良诊断算法。
Eur Radiol. 2023 Apr;33(4):2735-2745. doi: 10.1007/s00330-022-09282-5. Epub 2022 Dec 6.
3
Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis.过渡期和肝胆期低信号是否能改善 LI-RADS 分类作为替代廓清:系统评价和荟萃分析。
Eur Radiol. 2022 Aug;32(8):5134-5143. doi: 10.1007/s00330-022-08665-y. Epub 2022 Mar 10.
4
Interactive Explainable Deep Learning Model for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI: A Retrospective, Multicenter, Diagnostic Study.用于钆塞酸二钠增强MRI肝细胞癌诊断的交互式可解释深度学习模型:一项回顾性、多中心诊断研究
Radiol Imaging Cancer. 2025 May;7(3):e240332. doi: 10.1148/rycan.240332.
5
Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma.血清甲胎蛋白与LI-RADS v2018联合应用对钆塞酸增强MRI在肝细胞癌诊断和预后评估中的作用
Eur Radiol. 2025 Feb 10. doi: 10.1007/s00330-025-11418-2.
6
Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.钆塞酸增强 MRI 对肝细胞癌的诊断:在门脉期和肝胆期的廓清值的价值。
Radiology. 2019 Jun;291(3):651-657. doi: 10.1148/radiol.2019182587. Epub 2019 Apr 16.
7
Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.钆塞酸二钠增强MRI肝胆期的肝腺瘤亚型:系统评价与Meta分析
AJR Am J Roentgenol. 2023 Jan;220(1):28-38. doi: 10.2214/AJR.22.27989. Epub 2022 Aug 3.
8
Model Construction for Predicting Preoperative Microvascular Invasion of Hepatocellular Carcinoma by Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging Combined with Serology.钆塞酸二钠增强磁共振成像联合血清学预测肝细胞癌术前微血管侵犯的模型构建
Med Sci Monit. 2025 Jul 1;31:e947809. doi: 10.12659/MSM.947809.
9
Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis.钆塞酸二钠增强磁共振成像在诊断小肝细胞癌方面优于多排螺旋 CT:一项荟萃分析。
Liver Transpl. 2017 Dec;23(12):1505-1518. doi: 10.1002/lt.24867.
10
Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.钆塞酸二钠增强磁共振成像肝胆期上小于1厘米的低信号结节的影像学特征,这些结节在慢性肝病患者中进展为高血供肝细胞癌。
Acta Radiol. 2015 May;56(5):526-35. doi: 10.1177/0284185114534652. Epub 2014 May 16.

本文引用的文献

1
Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.添加肝胆期图像对磁共振成像检测肝细胞癌的性能:一项荟萃分析。
Eur Radiol. 2022 Nov;32(11):7883-7895. doi: 10.1007/s00330-022-08826-z. Epub 2022 May 17.
2
Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis.过渡期和肝胆期低信号是否能改善 LI-RADS 分类作为替代廓清:系统评价和荟萃分析。
Eur Radiol. 2022 Aug;32(8):5134-5143. doi: 10.1007/s00330-022-08665-y. Epub 2022 Mar 10.
3
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
HCC 监测可提高肝硬化患者的早期检测、根治性治疗的获得和生存率:一项荟萃分析。
J Hepatol. 2022 Jul;77(1):128-139. doi: 10.1016/j.jhep.2022.01.023. Epub 2022 Feb 6.
4
Added value of enhanced CT on LR-3 and LR-4 observation of Gd-EOB-DTPA MRI for the diagnosis of HCC: are CT and MR washout features interchangeable?钆塞酸二钠增强 MRI 中 LR-3、LR-4 观察对 HCC 诊断的 CT 增强的附加价值:CT 和 MR 洗脱特征是否可互换?
Br J Radiol. 2022 Apr 1;95(1132):20210738. doi: 10.1259/bjr.20210738. Epub 2022 Jan 5.
5
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis.GALAD 在肝硬化患者队列中对 HCC 监测具有很高的灵敏度。
Hepatology. 2022 Mar;75(3):541-549. doi: 10.1002/hep.32185. Epub 2021 Dec 17.
6
Noncontrast MRI for Hepatocellular Carcinoma Detection: A Systematic Review and Meta-analysis - A Potential Surveillance Tool?非对比 MRI 用于肝细胞癌检测:系统评价和荟萃分析 - 一种潜在的监测工具?
Clin Gastroenterol Hepatol. 2022 Jan;20(1):44-56.e2. doi: 10.1016/j.cgh.2021.02.036. Epub 2021 Mar 2.
7
Diagnostic performance of MRI using extracellular contrast agents versus gadoxetic acid for hepatocellular carcinoma: A systematic review and meta-analysis.磁共振成像使用细胞外对比剂与钆塞酸对比剂诊断肝细胞癌的性能:系统评价和荟萃分析。
Liver Int. 2021 May;41(5):1117-1128. doi: 10.1111/liv.14850. Epub 2021 Mar 8.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Subcentimeter hepatocellular carcinoma in treatment-naïve patients: noninvasive diagnostic criteria and tumor staging on gadoxetic acid-enhanced MRI.未经治疗的原发性小肝癌:钆塞酸增强 MRI 的无创性诊断标准与肿瘤分期。
Eur Radiol. 2021 Apr;31(4):2321-2331. doi: 10.1007/s00330-020-07329-z. Epub 2020 Oct 12.
10
Advances in functional and molecular MRI technologies in chronic liver diseases.慢性肝脏疾病的功能和分子 MRI 技术进展。
J Hepatol. 2020 Nov;73(5):1241-1254. doi: 10.1016/j.jhep.2020.06.020. Epub 2020 Jun 22.